Mounjaro Does Not Cause Sinus or Ear Pressure Based on Available Evidence
Sinus pressure and ear pressure are not documented side effects of Mounjaro (tirzepatide) in the FDA drug label or clinical trial data. The most common adverse reactions are gastrointestinal in nature—nausea, diarrhea, vomiting, constipation, and abdominal pain 1.
What the Evidence Shows
FDA-Approved Safety Profile
The official FDA drug label for Mounjaro lists comprehensive adverse reactions from pooled placebo-controlled trials involving thousands of patients 1. The documented side effects include:
- Gastrointestinal effects (most common): nausea (12-18%), diarrhea (12-17%), vomiting (5-9%), constipation (6-7%)
- Hypersensitivity reactions: urticaria, eczema, injection site reactions (3.2% vs 0.4% placebo)
- Cardiovascular: modest heart rate increases of 2-4 beats per minute
- Other: dysgeusia (taste changes), dysesthesia (abnormal sensations)
Notably absent from this extensive safety data are any reports of sinus congestion, sinus pressure, or ear pressure.
Emerging Case Report: Patulous Eustachian Tube
One recent case series identified a potential otologic complication in patients experiencing significant weight loss (8-18% body weight) on GLP-1 receptor agonists including tirzepatide 2. Seven patients developed patulous Eustachian tube (PET) after 4-10 months of therapy, presenting with:
- Autophony (hearing one's own voice loudly)
- Intermittent aural fullness
- Hearing one's own breathing
Critical distinction: This is not sinus or ear "pressure" but rather a sensation of ear fullness due to an abnormally patent (open) Eustachian tube caused by fat pad loss around the tube from rapid weight loss. This is mechanistically different from congestion or pressure.
Clinical Context
The comprehensive endocrinology guideline on tirzepatide emphasizes that the most common side effects are gastrointestinal, occurring primarily during dose escalation 3. The guideline makes no mention of sinonasal or otologic symptoms as recognized adverse effects.
What May Be Causing Your Symptoms
If you're experiencing sinus or ear pressure while taking Mounjaro, consider these alternative explanations:
Coincidental upper respiratory infection: Viral rhinosinusitis is extremely common and may occur independently of medication use 4.
Dehydration from GI side effects: Nausea, vomiting, and diarrhea can lead to dehydration 3, which may indirectly affect Eustachian tube function or cause headaches that mimic sinus pressure.
Rapid weight loss effect: If you've lost substantial weight (>8%), the rare patulous Eustachian tube phenomenon could cause ear fullness 2, though this typically presents with autophony rather than "pressure."
Pre-existing allergic or non-allergic rhinitis: Unrelated sinonasal conditions may become more noticeable or coincidentally flare during treatment.
Practical Recommendations
Do not attribute sinus/ear pressure to Mounjaro without ruling out other causes. The medication has been extensively studied in over 5,000 patients in clinical trials with no signal for these symptoms 1.
If symptoms persist:
- Evaluate for viral or bacterial rhinosinusitis using standard diagnostic criteria (symptoms >10 days, worsening after initial improvement, or severe symptoms with fever >39°C and purulent discharge) 4
- Ensure adequate hydration, especially if experiencing GI side effects
- Consider symptomatic treatment with nasal saline irrigation, intranasal corticosteroids, or analgesics as appropriate for rhinosinusitis 4
- If experiencing ear fullness with autophony after significant weight loss, consult an otolaryngologist to evaluate for patulous Eustachian tube 2
Continue Mounjaro unless directed otherwise by your prescriber, as these symptoms are not established adverse effects and discontinuation based on unrelated symptoms would sacrifice the medication's proven benefits for diabetes control and weight management.